NORDITROPIN

This brand name is authorized in Albania, Austria, Australia, Brazil, Canada, Spain, Finland, Ireland, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug NORDITROPIN contains one active pharmaceutical ingredient (API):

1 Somatropin UNII NQX9KB6PCL - SOMATROPIN

Somatropin is a potent metabolic hormone of importance for the metabolism of lipids, carbohydrates and proteins. In children with inadequate endogenous growth hormone, somatropin stimulates linear growth and increases growth rate. In adults, as well as in children, somatropin maintains a normal body composition by increasing nitrogen retention and stimulation of skeletal muscle growth, and by mobilization of body fat. Read about Somatropin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H01AC01	Somatropin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AC Somatropin and somatropin agonists
Discover more medicines within H01AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	Identifier(s): 123/93
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10432C, 10449Y, 10451C, 10467X, 10489C, 10496K, 11895C, 5818F, 5819G, 5820H
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526600911158411, 526602201158412, 526602202154410, 526602203150419, 526617020008203, 526617020008303, 526620080008007, 526620080008107, 526620080008207
Country: CA	Health Products and Food Branch	Identifier(s): 02334852, 02334860, 02334879
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 62977, 62978, 62979, 85644, 85645, 85646
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 017019, 017070, 025480
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 186369, 309380, 309383, 386089, 386093, 386095, 394083, 394086, 41042, 41052, 41993
Country: IE	Health Products Regulatory Authority	Identifier(s): 88114, 88115, 88830, 88831, 88832
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8086, 8087
Country: JP	医薬品医療機器総合機構	Identifier(s): 2412402P6027, 2412402P7023, 2412402P8020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004103, 1018082, 1018083, 1019767, 1019768, 1019769, 1037188, 1037189, 1057733, 1057734, 1091619, 1091620, 1091621, 1091622, 1091623, 1091624
Country: MT	Medicines Authority	Identifier(s): MA104/00103, MA104/00104, MA104/00105, MA104/00106
Country: NL	Z-Index G-Standaard	Identifier(s): 14286998, 14287005, 14287013
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 53082, 53090, 53104, 72729, 72745
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11501, 11502, 11503
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100157810, 100412811, 100436869
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W54046001, W54046002, W54046003, W66430001, W66430002, W66430003
Country: SG	Health Sciences Authority	Identifier(s): 12215P, 12219P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5993091H, 5993092H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699676950225, 8699676950232, 8699676950249
Country: US	FDA, National Drug Code	Identifier(s): 0169-7703, 0169-7704, 0169-7705, 0169-7708
Country: ZA	Health Products Regulatory Authority	Identifier(s): 33/21.10/0420, 33/21.10/0421, 33/21.10/0422